Applied Molecular Transport share#snapshot#suffix
shares#estimates#headline Applied Molecular Transport in USD
2025 | |
---|---|
shares#estimates#column#sales | |
shares#estimates#column#dividendspershare | |
shares#estimates#column#dividendyield | % |
shares#estimates#column#earningpersharebasic | |
shares#estimates#column#pricetoearningsratio | -0,39 |
shares#estimates#column#earningsbeforeinterestandtaxes | |
shares#estimates#column#earningsbeforeinteresttaxesdepreciationamortization | |
shares#estimates#column#netprofit | |
shares#estimates#column#netprofitadjusted | |
shares#estimates#column#pretaxprofit | |
shares#estimates#column#pretaxprofitreported | |
shares#estimates#column#earningpersharenongaap | |
shares#estimates#column#earningpersharereported | |
shares#estimates#column#grossincome | |
shares#estimates#column#cashflowfrominvesting | |
shares#estimates#column#cashflowfromoperations | |
shares#estimates#column#cashflowfromfinancing | |
shares#estimates#column#cashflowpershare | |
shares#estimates#column#freecashflow | |
shares#estimates#column#freecashflowpershare | |
shares#estimates#column#bookvaluepershare | |
shares#estimates#column#netdebt | |
shares#estimates#column#researchanddevelopment | |
shares#estimates#column#capitalexpenditure | |
shares#estimates#column#sellinggeneralandadministrativeexpense | |
shares#estimates#column#shareholdersequity | |
shares#estimates#column#totalassets |
shares#estimates#footer